Effects of Different Inspiratory Muscle Training Protocols on Exercise Capacity, Respiratory Muscle Strength, and Health-Related Quality of Life in Patients with Hypertension
Table 2
The results of the effect of IMT on respiratory parameters in individuals with HT.
CG (n: 15)
LLG (n: 15)
HLG (n: 15)
Treatment effect value
Pre mean ± SD
Post mean ± SD
Within group value
Pre mean ± SD
Post mean ± SD
Within group value
Pre mean ± SD
Post mean ± SD
Within group value
MIP (cmH2O)
74.46 ± 29.51
87.16 ± 35.19
<0.029
85.46 ± 23.90
110.16 ± 28.80
<0.001
88.53 ± 25.28
118.82 ± 30.45
<0.01
0.054
MEP (cmH2O)
74.20 ± 22.27
84.26 ± 29.35
0.115
88.53 ± 24.09
109.97 ± 31.94
0.001
93.80 ± 26.96
112.52 ± 41.23
0.006
0.465
FEV1 (lt)
2.64 ± 0.62
2.55 ± 0.77
0.304
2.88 ± 0.83
3.01 ± 0.67
0.116
3.05 ± 0.83
3.09 ± 0.95
0.546
0.785
FEV1 (%)
81.50 ± 13
85.20 ± 16.62
0.338
88.86 ± 23.40
92.56 ± 15.68
0.092
91.20 ± 18.56
91.98 ± 18.98
0.485
0.764
FEV1/FVC (%)
84.92 ± 10.50
87.70 ± 12.96
0.159
86.71 ± 8.71
84.80 ± 6.58
0.459
82.70 ± 84.69
84.69 ± 9.24
0.467
0.296
FVC (lt)
2.86 ± 0.70
2.95 ± 0.78
0.867
3.42 ± 0.99
3.91 ± 1.24
0.045
3.60 ± 1.27
4.26 ± 1.46
0.006
0.113
FVC (%)
80.21 ± 14.10
83.80 ± 15.18
0.328
87.40 ± 23.11
89.82 ± 15.45
0.253
91.06 ± 21.62
90.69 ± 22.97
0.807
0.283
PEF (lt)
4.21 ± 1.62
5.43 ± 2.38
0.011
5.24 ± 1.74
6.33 ± 2.26
0.007
5.32 ± 2.05
6.01 ± 1.93
0.071
0.734
PEF (%)
57.78 ± 15.09
74.46 ± 22.52
0.001
65.06 ± 20.90
77.23 ± 24.84
0.005
68.73 ± 19.59
80.65 ± 17.82
0.004
0.873
FEF25–75 (lt)
2.87 ± 1.24
3.01 ± 1.33
0.623
3.22 ± 1.09
3.52 ± 1.08
0.134
3.85 ± 1.52
4.03 ± 1.62
0.219
0.776
FEF25–75 (%)
75.71 ± 24.21
86.42 ± 27.73
0.040
86.53 ± 29.50
93.39 ± 29.50
0.110
92.86 ± 25.24
96.85 ± 28.41
0.269
0.762
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; PEF: peak expiratory flow; FEF%25–75 (%): forced expiratory flow at 25–75% of the pulmonary volume; MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure; . Paired t-test. ANCOVA test.
